Tag: low back pain
Mainstay announces publication of five-year follow-up data from ReActiv8-B trial
Mainstay Medical has announced the publication of the five-year follow-up from its ReActiv8-B randomised, sham-controlled, double-blinded trial in Neuromodulation: Technology at the Neural Interface.
There...
Review concludes SCS benefits do not outweigh associated risks and costs...
A recently published Cochrane review has concluded that the clinical benefits of spinal cord stimulation (SCS) do not outweigh the risks and costs associated...
Novel differential-target multiplexed technique outperforms conventional SCS
Continuous differential-target multiplexed (DTM) spinal cord stimulation (SCS) provides better thermal and mechanically induced pain relief compared to high-rate and low-rate SCS, concluded Ricardo...
SPR Therapeutics announces first use of SPRINT extensa dual-lead peripheral nerve...
SPR Therapeutics, a developer of neurostimulation technology for pain management, has announced that Christopher Gilmore of Carolinas Pain Institute was the first to use...
ReActiv8-A sustains performance at one year in clinical trial
Mainstay Medical International has announced the one-year results from the ReActiv8-A Clinical Trial, an international, multi-centre, prospective, single arm trial for ReActiv8 in people...
